Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG tracer in laparoscopic distal gastrectomy for early gastric cancer
NCT04973475Phase 2Not yet recruiting
- Sponsor
- Fujian Medical University
- Start
- Jul 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green in gastric adenocarcinoma, sponsored by Fujian Medical University. Primary endpoint: False negative rate at 1 month. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
indocyanine green
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT04973475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04973475.